Esfandyari, Tuba
University of Kansas Medical Center
3 papers on CoChat
Most cited papers
- Verified
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial
Sims, M. D., Khanna, S., Feuerstadt, P., Louie, T. J., Kelly, C. R., Huang, E. S., Hohmann, E. L., Wang, E. E. L., Oneto, C., Cohen, S. H., et al. (2023) · JAMA Network Open
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 83
- Verified
Ral signaling pathway in health and cancer
Moghadam, A. R., Patrad, E., Tafsiri, E., Peng, W., Fangman, B., Pluard, T. J., Accurso, A., Salacz, M., Shah, K., Ricke, B., et al. (2017) · Cancer Medicine
Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer
Cited by 58
- Verified
Short-term and Long-term Efficacy of Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-analysis
Khan, S., Shafiq, M., Khan, M. A., Ahmad, A., Ehsan, N., Ahmad, N., Tripathi, A., & Esfandyari, T. (2025) · Journal of Clinical Gastroenterology
Gastrointestinal motility and disordersGastroesophageal reflux and treatments
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free